Mostrar el registro sencillo del ítem

Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys

dc.creatorDegenhardt, Louisaes_ES
dc.creatorBharat, Chriannaes_ES
dc.creatorBruno, Raimondoes_ES
dc.creatorGlantz, Meyer D.es_ES
dc.creatorSampson, Nancy A.es_ES
dc.creatorLago, Luisees_ES
dc.creatorAguilar-Gaxiola, Sergioes_ES
dc.creatorAlonso, Jordies_ES
dc.creatorAndrade, Laura Helenaes_ES
dc.creatorBunting, Brendanes_ES
dc.creatorCaldas-de-Almeida, Jose Migueles_ES
dc.creatorCia, Alfredo H.es_ES
dc.creatorGureje, Oyees_ES
dc.creatorKaram, Elie G.es_ES
dc.creatorMohammad, Khalafes_ES
dc.creatorMc Grath, John J.es_ES
dc.creatorMoskalewicz, Jacekes_ES
dc.creatorLee, Singes_ES
dc.creatorMneimneh, Zeinaes_ES
dc.creatorNavarro-Mateu, Fernandoes_ES
dc.creatorSasu, Carmen C.es_ES
dc.creatorScott, Katees_ES
dc.creatorTorres, Yolandaes_ES
dc.creatorPoznyak, Vladimir
dc.creatorChatterji, Somnathes_ES
dc.creatorKessler, Ronald C.es_ES
dc.creatorWHO World Mental Health Survey Collaboratorses_ES
dc.creatorBenjet, Corinaes_ES
dc.creatorBorges, Guilhermees_ES
dc.creatorMedina-Mora, María Elenaes_ES
dc.date2019
dc.date.accessioned2022-07-15T20:03:28Z
dc.date.available2022-07-15T20:03:28Z
dc.date.issued2019es_ES
dc.identifierJC016es_ES
dc.identifier.issn0965-2140es_ES
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/7556
dc.identifier.urihttps://doi.org/10.1111/add.14482es_ES
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059958/es_ES
dc.descriptionBackground and aims: The World Health Organization's (WHO's) proposed International Classification of Diseases, 11th edition (ICD-11) includes several major revisions to substance use disorder (SUD) diagnoses. It is essential to ensure the consistency of within-subject diagnostic findings throughout countries, languages and cultures. To date, agreement analyses between different SUD diagnostic systems have largely been based in high-income countries and clinical samples rather than general population samples. We aimed to evaluate the prevalence of, and concordance between diagnoses using the ICD-11, The WHO's ICD 10th edition (ICD-10) and the Diagnostic and Statistical Manual of Mental Disorders, 4th and 5th editions (DSM-IV, DSM-5); the prevalence of disaggregated ICD-10 and ICD-11 symptoms; and variation in clinical features across diagnostic groups. Design: Cross-sectional household surveys. Setting: Representative surveys of the general population in 10 countries (Argentina, Australia, Brazil, Colombia, Iraq, Northern Ireland, Poland, Portugal, Romania and Spain) of the World Mental Health Survey Initiative. Participants: Questions about SUDs were asked of 12 182 regular alcohol users and 1788 cannabis users. Measurements: Each survey used the World Mental Health Survey Initiative version of the WHO Composite International Diagnostic Interview version 3.0 (WMH-CIDI). Findings: Among regular alcohol users, prevalence (95% confidence interval) of life-time ICD-11 alcohol harmful use and dependence were 21.6% (20.5-22.6%) and 7.0% (6.4-7.7%), respectively. Among cannabis users, 9.3% (7.4-11.1%) met criteria for ICD-11 harmful use and 3.2% (2.3-4.0%) for dependence. For both substances, all comparisons of ICD-11 with ICD-10 and DSM-IV showed excellent concordance (all κ ≥ 0.9). Concordance between ICD-11 and DSM-5 ranged from good (for SUD and comparisons of dependence and severe SUD) to poor (for comparisons of harmful use and mild SUD). Very low endorsement rates were observed for new ICD-11 feature for harmful use ('harm to others'). Minimal variation in clinical features was observed across diagnostic systems. Conclusions: The World Health Organization's proposed International Classification of Diseases, 11th edition (ICD-11) classifications for substance use disorder diagnoses are highly consistent with the ICD 10th edition and the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Concordance between ICD-11 and the DSM 5th edition (DSM-5) varies, due largely to low levels of agreement for the ICD harmful use and DSM-5 mild use disorder. Diagnostic validity of self-reported 'harm to others' is questionable.es_ES
dc.formatPDFes_ES
dc.language.isoenges_ES
dc.publisherWiley-Blackwelles_ES
dc.relation114(3)534-552es_ES
dc.rightsAcceso Cerradoes_ES
dc.titleConcordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveyses_ES
dc.typeArtículoes_ES
dc.contributor.affiliationNational Drug and Alcohol Research Centre, UNSW Sydney, 22-32 King St, Randwick NSW 2031, Australia.es_ES
dc.contributor.emaill.degenhardt@unsw.edu.aues_ES
dc.relation.jnabreviadoADDICTIONes_ES
dc.relation.journalAddictiones_ES
dc.identifier.placeInglaterraes_ES
dc.date.published2019es_ES
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñizes_ES
dc.identifier.eissn1360-0443es_ES
dc.identifier.doi10.1111/add.14482es_ES
dc.subject.kwAlcoholes_ES
dc.subject.kwCannabises_ES
dc.subject.kwDiagnosises_ES
dc.subject.kwDSM
dc.subject.kwICDes_ES
dc.subject.kwSubstance use disorderes_ES
dc.subject.kwWorld Mental Health Surveys


Ficheros en el ítem

Thumbnail
Nombre:
Addiction2019;114(3)534-552.pdf
Tamaño:
429.9Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem